secwatch.observer — SEC 8-K summary
======================================

Issuer:     LeonaBio, Inc. (LONA)
CIK:        0001620463
Form:       8-K
Filed at:   2024-05-29T23:59:59+00:00
Accession:  0000950170-24-065914
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Athira Pharma shareholders approve officer liability limitation charter amendment at 2024 annual meeting
--------------------------------------------------------------------------------

- Class I directors Kosacz, Litton, and Panzara elected with For votes ranging from 77% to 82% of votes cast (excl. broker non-votes).
- Ratification of Ernst & Young as auditor passed: 27,199,785 For, 59,069 Against, 99,855 Abstain.
- Amendment to certificate of incorporation limiting officer liability approved: 19,365,835 For, 602,307 Against, 347,812 Abstain.
- Broker non-votes were 7,042,755 on director election and charter amendment proposals.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1620463/000095017024065914/0000950170-24-065914-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1620463/000095017024065914/atha-20240523.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-065914

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer